- Bicycle Therapeutics currently has 5 oncology candidates in development
- The company also has development projects underway outside of the oncology arena
Bicycle... read more
Bicycle... read more
Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced on 11/13/18 that it has completed a $30 million Series A... read more
NeuroRx, announced on 11/13/18 that it has been granted... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,